Med Tech-related technology assessments and clinical guidelines from NICE in April 2020

In April 2020, the National Institute for Health and Care Excellence (NICE) published only one new medical technologies guidance (for PneuX to prevent ventilator-associated pneumonia) and two Medtech innovation briefings (for Lifelight First for monitoring vital signs and myCOPD for self-management of chronic obstructive pulmonary disease).

In April, NICE published one new Medical Technologies Guidance PneuX to prevent ventilator-associated pneumonia covers evidence-based recommendations on PneuX to prevent ventilator-associated pneumonia. PneuX shows positive data for preventing ventilator-associated pneumonia in adults. However, there is currently not enough good-quality evidence to support the case for routine adoption in the NHS. Research is recommended to address uncertainties about the clinical benefits of using PneuX.

MedTech Innovation Briefing is the NICE's advice program for innovative technologies. It provides an overview of clinical effectiveness, safety, and cost. It does not offer formal guidance, and it, therefore, does not provide any recommendations.

Two new Medtech Innovation Briefings for Lifelight First for monitoring vital signs (used for measuring indicative estimates of blood pressure, pulse rate, and respiration rate  in people who need vital sign measurements) and myCOPD for self-management of chronic obstructive pulmonary disease (helps people with chronic obstructive pulmonary disease (COPD) to manage their symptoms and reduce the number of healthcare visits they need) have been published in April.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.